Crystalsfirst

Small-molecule drug discovery is being compared to searching for a needle in a haystack. At CrystalsFirst, we have built a better way: using a “magnet” to attract the best-suited molecules. MAGNET Discovery Engine accelerates small molecule drug discovery by uniting patented high-throughput structural biology with AI-powered design. This integration of vertically scaling proprietary “labware” with horizontally scaling of AI-driven design tools offers the industry to systematically uncover, validate, and optimize ligands with a speed and confidence that was previously out of reach. With a track record of over 60 structurally-enabled drug targets, the MAGNET has been applied successfully across: target-to-hit discovery, hit-to-lead development, lead optimization.